SCHEMBL320037

SCHEMBL320037

NC(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
TSHR P16473 3/20 0.50
PBRM1 Q86U86 1/20 0.49
POLB P06746 1/20 0.47
FEN1 P39748 1/20 0.47
PARP1 P09874 1/20 0.46
HPGD P15428 2/20 0.45
NPC1 O15118 1/20 0.45
GLA P06280 1/20 0.45
KMT2A Q03164 3/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP3A4 P08684 2/20 0.44
ADRA2A P08913 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
HTR1A P08908 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29008206 0.97 ALDH1A1 (0.58) ALDH1A1TSHRPBRM1POLBFEN1
SCHEMBL17329160 0.86 ALDH1A1 (0.52) ALDH1A1TSHRPBRM1POLBFEN1
SCHEMBL145510 0.86 ALDH1A1 (0.52) ALDH1A1TSHRPBRM1POLBFEN1
SCHEMBL1135187 0.86 ALDH1A1 (0.52) ALDH1A1TSHRPBRM1PARP1HPGD
SCHEMBL793494 0.84 ALDH1A1 (0.50) ALDH1A1TSHRPBRM1POLBFEN1
SCHEMBL15540940 0.84 ALDH1A1 (0.50) ALDH1A1TSHRPBRM1POLBFEN1
SCHEMBL2867748 0.84 PBRM1 (0.58) ALDH1A1PBRM1KMT2AMEN1LMNA
SCHEMBL1397518 0.84 TSHR (0.51) ALDH1A1TSHRPBRM1POLBFEN1
SCHEMBL1805872 0.84 ALDH1A1 (0.50) ALDH1A1TSHRPBRM1POLBFEN1
Hydrochloric Acid SCHEMBL4372223 0.83 TSHR (0.50) ALDH1A1TSHRPBRM1POLBFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 684 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118754844-A Preparation method of diclofenac sodium intermediate 世华合创生物技术开发(山东)有限公司 2024-10-11 CN claimed
CN-115047107-B Method for detecting residues of fluopicolide, cyazofamid and metabolites thereof on ginseng 山东省农业科学院 2024-03-19 CN claimed
US-20240002344-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION FIBROGEN, INC. 2024-01-04 US claimed
CN-117110458-A Method for detecting halogenated benzamide by solid phase extraction-liquid chromatography tandem mass spectrometry 浙江工业大学 2023-11-24 CN claimed
US-11708322-B2 Process for preparation of 2,6-dichlorobenzonitrile ARYSTA LIFESCIENCE INC. (US) 2023-07-25 US claimed
EP-4204400-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION Fibrogen, Inc. (US) 2023-07-05 EP claimed
CN-116348450-A Compounds, compositions and methods for histone lysine demethylase inhibition 菲布罗根有限公司 2023-06-27 CN claimed
CN-113038835-B Preparation method of 2, 6-dichlorobenzonitrile 爱利思达生命科学有限公司 2023-03-28 CN claimed
CN-115047107-A Method for detecting residues of fluopicolide, cyazofamid and metabolites thereof on ginseng 山东省农业科学院 2022-09-13 CN claimed
CN-112305131-B GC-Orbitrap-MS screening and analyzing method for pesticide residues in animal derived food 中国农业科学院农业质量标准与检测技术研究所 2021-09-21 CN claimed
EP-1204866-A2 IMMUNOASSAY FOR PESTICIDES AND THEIR DEGRADATION PRODUCTS Exiqon A/S (DK) 2002-05-15 EP claimed
US-6262040-B1 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) PFIZER INC 2001-07-17 US claimed
WO-2001007912-A2 IMMUNOASSAY FOR PESTICIDES AND THEIR DEGRADATION PRODUCTS EXIQON A/S (US) 2001-02-01 WO claimed
US-6180637-B1 THERAPY FOR PARKINSON, ALZHEIMER DISEASE ARZNEIMITTELWERK DRESDEN GMBH (DE) 2001-01-30 US claimed
EP-0931075-A1 INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE (PDE) TYPE IV AND THE PRODUCTION OF TUMOR NECROSIS FACTOR (TNF) PFIZER INC. (US) 1999-07-28 EP claimed
WO-1998009961-A1 INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE (PDE) TYPE IV AND THE PRODUCTION OF TUMOR NECROSIS FACTOR (TNF) PFIZER INC. (US) 1998-03-12 WO claimed
CN-1087920-A The enzymatic of phenol and aromatic amine high molecular polymer is synthetic UNIV JILIN (CN) 1994-06-15 CN claimed
WO-1993014062-A1 ANTHELMINTIC β-KETOAMIDES THE UPJOHN COMPANY (US) 1993-07-22 WO claimed
US-5096710-A Cockroaches, juvenile hormone or chitin synthesis inhibitor, dextrin, plant oil SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-03-17 US claimed
US-4942232-A FOR PRINTING AND DYEING CELLULOSE FIBERS BASF AKTIENGESELLSCHAFT (DE) 1990-07-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708322-B2 Process for preparation of 2,6-dichlorobenzonitrile DDT, DCUN1D2, DCUN1D4 ALDH1A1 1703/4885TSHR 3640/4885PBRM1 669/4885
US-20240002344-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION KDM5C, KDM5B, KDM5A ALDH1A1 2449/4885TSHR 4662/4885PBRM1 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.